RxDoctor Payments Data

Karla Feliciano Salva

Hematology & Oncology · San Juan, PRNPI 1043766983

Payments from drug & device makers

What this record shows

This record is dominated by grants: $37,778 of the $44,274 with a category attached, or 85.3%. AbbVie accounts for 87.8% of it on its own, with 28 other manufacturers making up the rest. Reporting peaked in 2021 at $39,063 and has fallen 99.4% since, to $252 in 2025.

$44,274in general payments, 2019–2025

Across 233 payments — averaging $190.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$39K
  • Amgen$884
  • Johnson & Johnson$686
  • E.r. Squibb & Sons, L.L.C.$668
  • Genentech USA, Inc.$376
  • PBG Puerto Rico LLC$373
  • plus $2K from 23 others

What the payments were for

  • Grants$37,77885%
  • Food & beverage$6,07414%
  • Education$4231%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$44,274 in reported general payments places this provider in the 85th percentile of 138 hematology & oncology providers in Puerto Rico.

See all hematology & oncology providers in Puerto Rico

Other hematology & oncology in San Juan

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →